RadNet, Inc.
RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
1D
-2.3%
1W
-3.0%
1M
-9.2%
6M
+13.9%
YTD
-3.6%
1Y
-11.1%
2Y
-2.2%
5Y
+139.1%
10Y
+818.6%
Next earnings date
09/11/2026 (in 23 days)
Volatility around earnings
~26% stronger price swings than usual
Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 14/10/26. Not a buy or sell signal.Beta
What does this mean?
Double top
BearishThe price failed at a similar high twice, with a pullback in between. This M-shaped pattern is a classic reversal signal from an uptrend into a downtrend.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
PRICE TARGET LOW
US$65.00
CONSENSUS
US$65.00
MEDIAN
US$65.00
PRICE TARGET HIGH
US$65.00
1
STRONG BUY
8
BUY
2
HOLD
0
SELL
0
STRONG SELL
11
TOTAL · Buy
As of: 28/08/2026
P/E
-258.16
P/B
4.88
EV/EBITDA
24.77
RETURN ON EQUITY
0.7%
NET MARGIN
1.2%
DEBT/EQUITY
1.99
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
FREE FLOAT
89.5%
FLOAT SHARES
70,416,824
AVG. DAILY VOLUME (30D)
673,095
SWARTZ DAVID L
Berger Howard G
Wesdorp Cornelis
Forthuber Stephen M
Forthuber Stephen M
RadNet, Inc. is a company in the Healthcare sector, Medical - Diagnostics & Research industry, headquartered in United States.
The CEO is Howard G. Berger, the company employs around 9,060 people.
The IPO was on 03/01/1997; the stock trades on NASDAQ under the ticker RDNT.
11 analysts rate the stock, the consensus is Buy (as of 28/08/2026).
The average price target is US$65.00, ranging from US$65.00 to US$65.00, with a median of US$65.00.
This is an external assessment, not a statement by Market Jury.
The next earnings date is 09/11/2026.
Around past earnings, price swings were roughly 26% stronger than usual.
No, RadNet currently does not pay a dividend.
Comparable stocks include Thermo Fisher Scientific, Danaher, Natera, Agilent Technologies, IQVIA Holdings, Waters, Illumina and IDEXX Laboratories.
Clicking "Analyze stock" lets five strategies assess RadNet against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.